Form 4: CERUS Corp. Director Shan Hua Reports Significant RSU Grant

CERUS Corp. Director Shan Hua reported the acquisition of 60,000 Restricted Stock Units (RSUs) on June 3, 2025, increasing her total beneficial ownership to 132,386 shares.

Summary

• Director Shan Hua of CERUS Corp. (CERS) acquired 60,000 shares of common stock on June 3, 2025.
• These shares were acquired as Restricted Stock Units (RSUs) with a transaction price of $0, indicating a grant rather than a cash purchase.
• The RSUs were granted under the Issuer's 2024 Equity Incentive Plan.
• Each RSU represents a contingent right to receive one share of common stock.
• The RSUs vest on the earlier of the first anniversary of the grant date or the day prior to the next annual meeting of stockholders, contingent on continuous service.
• Following this transaction, Ms. Shan Hua beneficially owns a total of 132,386 shares of CERUS Corp. common stock.

Sentiment

Score: 7

Explanation: The document reports a standard equity grant to a director, which is generally a positive sign of alignment between management/board and shareholder interests. It doesn't contain any negative financial news or operational issues.

Positives

• The grant of 60,000 Restricted Stock Units (RSUs) to Director Shan Hua aligns her interests with long-term shareholder value, as the RSUs vest based on continued service.
• The use of the 2024 Equity Incentive Plan indicates the company's commitment to incentivizing key personnel and retaining talent.

Negatives

• No direct negatives are apparent from this Form 4 filing, as it primarily reports a routine equity grant.

Risks

• The vesting of the RSUs is subject to the reporting person's continuous service to the Issuer, meaning the shares are not immediately owned and could be forfeited if service ceases before the vesting date.

Future Outlook

The vesting schedule for the granted RSUs indicates a future commitment from the director, with vesting occurring on the earlier of the first anniversary of the grant date or the day prior to the next annual meeting of stockholders, subject to continuous service.

Industry Context

Equity grants like Restricted Stock Units (RSUs) are a common form of executive and director compensation across various industries, including the biotechnology and medical device sectors where CERUS Corp. operates. They are used to align the interests of insiders with long-term shareholder value by tying compensation to continued service and potential stock price appreciation.

Comparison to Industry Standards

• The grant of RSUs at a $0 price is standard practice for equity incentive plans, aligning with common compensation structures in the biotechnology and medical technology industries.
• The vesting schedule (earlier of one year or prior to next annual meeting) is a typical short-to-medium term vesting period for director equity awards, comparable to practices at similar-sized companies in the sector.
• The total beneficial ownership of 132,386 shares for a director is a significant holding, demonstrating a material stake in the company's performance, which is generally viewed positively by investors.

Corporate Governance

Stakeholder Impact

• **Shareholders:** The RSU grant aligns the director's interests with shareholders, as the value of the RSUs is tied to the company's stock performance. It also signals confidence from the board member.
• **Employees:** While not directly impacting all employees, the use of an equity incentive plan can be seen as a positive signal regarding the company's approach to compensation and retention of key personnel.

Next Steps

• The RSUs granted to Director Shan Hua will vest on the earlier of the first anniversary of the grant date (June 3, 2026) or the day prior to the next annual meeting of stockholders, subject to continuous service.

Key Dates

Recommendation

Keywords

CERUS CORP, CERS, Form 4, SEC filing, Restricted Stock Units, RSU, equity incentive plan, insider transaction, director compensation, beneficial ownership